Stockreport

Magenta Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to MGTA-456 for the Treatment of Inherited Metabolic Disorders

Magenta Therapeutics, Inc.  (MGTA) 
Last magenta therapeutics, inc. earnings: 11/13 08:00 am Check Earnings Report
PDF CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power [Read more]